Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

44
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
44

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mobile cognitive testing captures divergent longitudinal trajectories of verbal learning in adults with and without HIV.

Frontiers in digital health·2026
Same author

Does today's workload predict tomorrow's stress, fatigue, and other strain states? Exploring directionality in daily dynamics.

Ergonomics·2026
Same author

Humanizing "multimodal" digital phenotyping of serious mental illness.

Journal of psychopathology and clinical science·2026
Same author

A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 2: Perceived Changes in Subjective Quality of Life and Medication Satisfaction.

Schizophrenia bulletin open·2026
Same author

Improving Thinking Through Everyday Self-Assessment Training (iTEST): Results of the Initial Open Trial to Improve Introspective Accuracy in Schizophrenia.

Schizophrenia bulletin·2026
Same author

Urinary pesticide biomarker associations with depression and anxiety scores from adolescence into young adulthood in the ESPINA cohort.

Journal of psychiatric research·2026
Same journal

Development of Physical Activity from Childhood to Adolescence in Offspring at Familial High Risk of Schizophrenia or Bipolar Disorder and Population-Based Controls: The Danish High Risk and Resilience Study.

Schizophrenia bulletin open·2026
Same journal

Social Network Analysis in Schizophrenia: What it Adds to our Understanding of Social Functioning and Loneliness.

Schizophrenia bulletin open·2026
Same journal

Impact of Healthcare Professional Role and Care Setting on Attitudes Toward Long-Acting Injectable Antipsychotics for Schizophrenia: A Subgroup Analysis of the Multinational ADVANCE Study.

Schizophrenia bulletin open·2026
Same journal

Detecting Features of Interpersonal Difficulties in First-Person Accounts of Schizophrenia; Automated Linguistic and Network Analyses.

Schizophrenia bulletin open·2026
Same journal

Comparing Public Attitudes to Traditional Biomedical Versus Trauma-Informed Approaches in Psychosis Services.

Schizophrenia bulletin open·2026
Same journal

Disentangling Psychopathology and Social Cognition in 22q11.2 Deletion Syndrome with Psychotic Symptoms and Schizophrenia.

Schizophrenia bulletin open·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.2K

Rationale and Challenges for a New Instrument for Remote Measurement of Negative Symptoms.

David Gordon Daniel1,2,3, Alex S Cohen4, Philip D Harvey5

  • 1Signant Health, Blue Bell, PA, USA.

Schizophrenia Bulletin Open
|November 6, 2024
PubMed
Summary
This summary is machine-generated.

Clinician-administered scales for negative symptoms have limitations. A new multimodal instrument using ecological momentary assessment (EMA) and digital measures is proposed to improve accuracy and capture daily experiences.

Keywords:
digital measuresecological momentary assessmentnegative symptomsrating scaleremote measurementschizophrenia

More Related Videos

Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
11:21

Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data

Published on: July 27, 2018

8.2K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

3.7K

Related Experiment Videos

Last Updated: Jun 8, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.2K
Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
11:21

Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data

Published on: July 27, 2018

8.2K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

3.7K

Area of Science:

  • Psychiatry
  • Clinical Neuroscience
  • Digital Health

Background:

  • Clinician-administered rating scales for negative symptoms exhibit significant limitations.
  • These include reliance on self-report, potential sampling bias, and subjectivity, hindering accurate assessment of daily-life experiences.

Purpose of the Study:

  • To initiate the development of a multimodal negative symptom instrument.
  • To address the limitations of current assessment methods for negative symptoms.

Main Methods:

  • Experts reviewed current methods for assessing negative symptom domains: affect, sociality, verbal communication, goal-directed behavior, and hedonic drives.
  • Recommended new approaches include ecological momentary assessment (EMA) via smartphone prompts and direct inference from smartphone-captured audio/visual or sensor data.

Main Results:

  • Identified limitations in current clinician-administered scales for negative symptom assessment.
  • Proposed a multimodal instrument incorporating EMA and digital measures for enhanced accuracy and ecological validity.

Conclusions:

  • The development of a multimodal negative symptom instrument is feasible.
  • While challenges exist in developing EMA and digital measures, they are surmountable, offering a promising future for negative symptom assessment.